Position
Altrafin AG in Stem, Inc.
Back to the book · All holders of STEM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.13K$5.67 → $5.72
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2021 | 41K | $777.6K | — | — | — | 0.3% |
| Q1 2022 | 70.4K | $775.4K | $11.01 | −$326.3K | $324K | 0.3% |
| Q2 2022 | 70.1K | $502.1K | $7.16 | −$270K | −$3.35K | 0.3% |
| Q3 2022 | 55.2K | $736.5K | $13.34 | $341.2K | −$106.7K | 0.4% |
| Q4 2022 | 42.7K | $381.9K | $8.94 | −$188K | −$166.7K | 0.2% |
| Q1 2023 | 42.7K | $242.1K | $5.67 | −$139.6K | −$206 | 0.1% |
| Q2 2023 | 42.7K | $244.1K | $5.72 | $2.13K | −$130 | 0.1% |